NVAX241018C4000
- 6.70
- -5.70-45.97%
Novavax Newsroom
How Bad Is This News for Novavax?
Express News | EMA: Chmp Gave Positive Opinions to Update Composition of Nuvaxovid and Bimervax
Novavax (NVAX) Advances While Market Declines: Some Information for Investors
Novavax Stock Plummets as FDA Pauses Clinical Trial on Safety Concerns -- Barrons.com
Novavax Stock Falls After FDA Puts Two Vaccine Programs on Hold
Novavax Reports FDA Placed Clinical Hold on IND for COVID-flu Combo Vaccine
J.P. Morgan Maintains Novavax(NVAX.US) With Sell Rating, Maintains Target Price $9
Novavax's Regulatory Setback and Mid-Term Underperformance: An Analyst's Perspective
Robinhood, Novavax, Phunware, Lucid Group, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
These Stocks Moved the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, DJT, Novavax, J.B. Hunt, Cisco, and More -- Barrons.com
Market Climbs Wednesday, While Morgan Stanley Earnings Beat | Wall Street Today
Novavax Analyst Ratings
Jefferies Maintains Novavax(NVAX.US) With Buy Rating, Cuts Target Price to $25
Cautious Optimism for Novavax Amid Clinical Hold Challenges
Jefferies Cuts Novavax's Price Target to $25 From $31, Buy Rating Maintained
Novavax Price Target Lowered to $25 From $31 at Jefferies
Dow Jumps 250 Points; U.S. Bancorp Earnings Top Views
Novavax Stock Plummets 17% as FDA Pauses Clinical Trial on Safety Concerns -- Barrons.com
Swelling Losses Haven't Held Back Gains for Novavax (NASDAQ:NVAX) Shareholders Since They're up 190% Over 5 Years
Big Tech is in a Race for Nukes to Power AI | The Daily Trade